Cargando…

PSMD4 is a novel therapeutic target in chemoresistant colorectal cancer activated by cytoplasmic localization of Nrf2

Nuclear Nrf2 (nNrf2) binding to the antioxidant response element may promote chemoresistance in colorectal cancer. However, the shuttling of Nrf2 between cytoplasm and nucleus in colon cancer cells has revealed the possibility that cytoplasmic location of Nrf2 (cNrf2) may play a specific role in che...

Descripción completa

Detalles Bibliográficos
Autores principales:	Cheng, Ya-Min, Lin, Po-Lin, Wu, De-Wei, Wang, Lee, Huang, Chi-Chou, Lee, Huei
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2018
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5995171/ https://www.ncbi.nlm.nih.gov/pubmed/29899863 http://dx.doi.org/10.18632/oncotarget.25254

Ejemplares similares

PSMD8 can serve as potential biomarker and therapeutic target of the PSMD family in ovarian cancer: based on bioinformatics analysis and in vitro validation
por: Li, Xiao, et al.
Publicado: (2023)

Cytoplasmic, but not nuclear Nrf2 expression, is associated with inferior survival and relapse rate and response to platinum‐based chemotherapy in non‐small cell lung cancer
por: Chen, Ming‐Jenn, et al.
Publicado: (2020)

PSMD12 promotes glioma progression by upregulating the expression of Nrf2
por: Wang, Zhongyong, et al.
Publicado: (2021)

Mutant p53 confers chemoresistance in non-small cell lung cancer by upregulating Nrf2
por: Tung, Min-Che, et al.
Publicado: (2015)

Identification of PSMD14 as a potential novel prognosis biomarker and therapeutic target for osteosarcoma
por: Gong, Yubao, et al.
Publicado: (2021)

Targeting Nrf2 Signaling to Combat Chemoresistance
por: No, Jae Hong, et al.
Publicado: (2014)

26S Proteasome Non-ATPase Regulatory Subunits 1 (PSMD1) and 3 (PSMD3) as Putative Targets for Cancer Prognosis and Therapy
por: Rubio, Andres J., et al.
Publicado: (2021)

The deubiquitinating enzyme PSMD14 facilitates tumor growth and chemoresistance through stabilizing the ALK2 receptor in the initiation of BMP6 signaling pathway
por: Seo, Dongyeob, et al.
Publicado: (2019)

NKX6.1 Represses Tumorigenesis, Metastasis, and Chemoresistance in Colorectal Cancer
por: Chung, Hsin-Hua, et al.
Publicado: (2020)

PSMD14 Targeting Triggers Paraptosis in Breast Cancer Cells by Inducing Proteasome Inhibition and Ca(2+) Imbalance
por: Lee, Hong-Jae, et al.
Publicado: (2022)

DDX3 enhances oncogenic KRAS-induced tumor invasion in colorectal cancer via the β-catenin/ZEB1 axis
por: Wu, De-Wei, et al.
Publicado: (2016)

Triptolide Downregulates the Expression of NRF2 Target Genes by Increasing Cytoplasmic Localization of NRF2 in A549 Cells
por: Nam, Le Ba, et al.
Publicado: (2021)

Haploinsufficiency of PSMD12 Causes Proteasome Dysfunction and Subclinical Autoinflammation
por: Yan, Kai, et al.
Publicado: (2022)

Targeting PSMD14 inhibits melanoma growth through SMAD3 stabilization
por: Yokoyama, Satoru, et al.
Publicado: (2020)

PSMD1 and PSMD2 regulate HepG2 cell proliferation and apoptosis via modulating cellular lipid droplet metabolism
por: Tan, Yanjie, et al.
Publicado: (2019)

Hsa-miR-1248 suppressed the proliferation, invasion and migration of colorectal cancer cells via inhibiting PSMD10
por: Wang, Chengxing, et al.
Publicado: (2022)

PSMD2 contributes to the progression of esophageal squamous cell carcinoma by repressing autophagy
por: Liu, Yachen, et al.
Publicado: (2023)

Paxillin promotes colorectal tumor invasion and poor patient outcomes via ERK-mediated stabilization of Bcl-2 protein by phosphorylation at Serine 87
por: Huang, Chi-Chou, et al.
Publicado: (2015)

PSMD9 expression predicts radiotherapy response in breast cancer
por: Langlands, Fiona E, et al.
Publicado: (2014)

Prognostic Significance of PSMD1 Expression in Patients with Gastric Cancer
por: Xiong, Wenjun, et al.
Publicado: (2019)

Upregulation of PSMD4 gene by hypoxia in prostate cancer cells
por: AYDOĞAN TÜRKOĞLU, Sümeyye, et al.
Publicado: (2020)

Prognostic Implication and Immunological Role of PSMD2 in Lung Adenocarcinoma
por: Zhao, Huihui, et al.
Publicado: (2022)

The YAP1/SIX2 axis is required for DDX3-mediated tumor aggressiveness and cetuximab resistance in KRAS-wild-type colorectal cancer
por: Wu, De-Wei, et al.
Publicado: (2017)

A variant of PSMD6 is associated with the therapeutic efficacy of oral antidiabetic drugs in Chinese type 2 diabetes patients
por: Chen, Miao, et al.
Publicado: (2015)

PSMD11 modulates circadian clock function through PER and CRY nuclear translocation
por: Cal-Kayitmazbatir, Sibel, et al.
Publicado: (2023)

DDX3 promotes tumor invasion in colorectal cancer via the CK1ε/Dvl2 axis
por: He, Tsung-Ying, et al.
Publicado: (2016)

Blockade of deubiquitinating enzyme PSMD14 overcomes chemoresistance in head and neck squamous cell carcinoma by antagonizing E2F1/Akt/SOX2-mediated stemness
por: Jing, Chao, et al.
Publicado: (2021)

PSMD2 promotes the progression of bladder cancer and is correlated with immune infiltration
por: Wang, Song, et al.
Publicado: (2022)

The prognostic role of PSMD14 in head and neck squamous cell carcinoma
por: Schnoell, Julia, et al.
Publicado: (2022)

miR-214 regulates papillary thyroid carcinoma cell proliferation and metastasis by targeting PSMD10
por: Liu, Fangzhou, et al.
Publicado: (2018)

Proteasome 26S subunit, non-ATPases 1 (PSMD1) and 3 (PSMD3), play an oncogenic role in chronic myeloid leukemia by stabilizing nuclear factor-kappa B
por: Bencomo-Alvarez, Alfonso E., et al.
Publicado: (2021)

PSMD9 expression correlates with recurrence after radiotherapy in patients with cervical cancer
por: Köster, Frank, et al.
Publicado: (2020)

Upregulation of deubiquitinase PSMD14 in lung adenocarcinoma (LUAD) and its prognostic significance
por: Zhang, Ling, et al.
Publicado: (2020)

Generation and identification of a conditional knockout allele for the PSMD11 gene in mice
por: Zhao, Linlin, et al.
Publicado: (2021)

Depletion of PSMD14 suppresses bladder cancer proliferation by regulating GPX4
por: Jia, Changxin, et al.
Publicado: (2023)

The PSMD14 inhibitor Thiolutin as a novel therapeutic approach for esophageal squamous cell carcinoma through facilitating SNAIL degradation
por: Jing, Chao, et al.
Publicado: (2021)

Genetically incorporated crosslinkers reveal NleE attenuates host autophagy dependent on PSMD10
por: Li, Jingxiang, et al.
Publicado: (2021)

The Nrf2/HO-1 Axis in Cancer Cell Growth and Chemoresistance
por: Furfaro, A. L., et al.
Publicado: (2016)

Dysregulation of Nrf2 in Hepatocellular Carcinoma: Role in Cancer Progression and Chemoresistance
por: Raghunath, Azhwar, et al.
Publicado: (2018)

Control of Oxidative Stress in Cancer Chemoresistance: Spotlight on Nrf2 Role
por: Barrera, Giuseppina, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_7qdtm2a5comrui7bnb83giuokv